Cohen's syndrome (VPS13B) gene analysis

Cohen's Syndrome (VPS13B) Gene Analysis

Cohen's Syndrome (VPS13B) Gene Analysis is a genetic test used to detect disease-causing variants in the VPS13B (COH1) gene, which is associated with Cohen's syndrome, a rare inherited disorder affecting growth, development, vision, and overall health. This test helps confirm the diagnosis, supports genetic counseling, and aids in family planning.

Test Details

• Sample Type: Peripheral Blood
• Method: DNA Sequencing (NGS/Sanger Sequencing as applicable)
• Report Time: 2–4 Weeks

Who Should Consider This Test?

• Children with developmental delay or intellectual disability
• Individuals with microcephaly (small head size)
• Patients with characteristic facial features suggestive of Cohen's syndrome
• Individuals with retinal dystrophy or progressive vision problems
• Those with unexplained low muscle tone (hypotonia)
• Families with a history of Cohen's syndrome

Symptoms Associated with Cohen's Syndrome

• Developmental delay
• Intellectual disability
• Poor muscle tone (hypotonia)
• Short stature
• Joint hypermobility
• Progressive vision impairment
• Obesity developing during childhood or adolescence
• Frequent infections due to low white blood cell counts (neutropenia)

Benefits of the Test

• Confirms the genetic diagnosis
• Enables early medical intervention and supportive care
• Assists in prognosis and long-term management
• Identifies carriers within the family
• Supports reproductive and prenatal counseling
• Helps differentiate Cohen's syndrome from other genetic disorders with similar symptoms

Preparation

No special preparation or fasting is required before sample collection.

Interpretation

• Positive: A pathogenic or likely pathogenic variant in the VPS13B gene is detected, confirming Cohen's syndrome.
• Negative: No clinically significant variant is identified in the analyzed regions. A negative result does not completely exclude the disorder if variants exist outside the tested regions.
• Variant of Uncertain Significance (VUS): A genetic change is detected, but its clinical significance is currently unknown and may require further evaluation.

Early genetic diagnosis can help guide appropriate clinical management, multidisciplinary care, and informed family planning.